Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mobilan in Prostate Cancer
NCT02654938Phase 1Completed
- Sponsor
- Panacela Labs
- Start
- Jul 2015
- Primary completion
- Sep 2017
- Modality
- Gene Editing, Gene Silencing, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in prostate cancer (PCa) comparing Mobilan with Placebo (2 arms). Primary endpoint: Frequency and intensity of adverse events at 29 days. Started Jul 2015; status: completed.
02
Drugs
mobilan
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02654938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02654938.